Enoxaparin versus Heparin: The SYNERGY Trial from an Emergency Medicine Perspective

Author： Rokos Ivan C.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.10, 2005-01, pp. : 1313-1316

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin in Patients with Acute Coronary Syndrome in Poland: Modelling Study from the Hospital Perspective

By Orlewska E.  

PharmacoEconomics, Vol. 21, Iss. 10, 2003-01 ,pp. : 737-748

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Enoxaparin Sodium versus Heparin in Unstable Angina: A French Sub-Study of the ESSENCE Trial

By Detournay B.  

PharmacoEconomics, Vol. 18, Iss. 1, 2000-07 ,pp. : 83-89

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin for Acute Coronary Syndromes: A Canadian Hospital Perspective

By Balen R.M.  

PharmacoEconomics, Vol. 16, Iss. 5, 1999-11 ,pp. : 533-542

Adis International

Access to resources Recommend Favorite

SYNERGY: enoxaparin an alternative to heparin in ACS?

By  

Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Enoxaparin vs heparin: the 6-month and 1-year SYNERGY results

By  

Inpharma, Vol. 1, Iss. 1516, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite